Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Pharmaceutical Biotechnology : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das
| Advances in Pharmaceutical Biotechnology : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (xviii, 478 pages) ; 92 illustrations, 56 illustrations in colour |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical technology
Biomedical engineering Pharmacotherapy Biotechnology Drug resistance Biochemistry Biotecnologia farmacèutica Quimioteràpia Pharmaceutical Sciences/Technology Biomedical Engineering/Biotechnology Drug Resistance Biochemistry, general |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-2195-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. Traditional And Ethnomedicine -- 1.Traditional Folk Medicine And Drug Discovery: Prospects And Outcome -- 2.Ethnomedicine For Drug Discovery -- 3.Medicinal And Aromatic Plants: Store House To Herbal Antimicrobials -- 4.Ethnomedicinal Plants Of North-East India As A Potential Target For Drug Discovery Against Type 2 Diabetes Mellitus -- 5.Application Of Phytochemicals In Pharmaceuticals -- 6.The Herbal Drugs -- 7.Role Of Natural Products As Alternative Of Synthetic Steroidal Drugs -- 8.Phytochemicals As Therapeutics In Heavy Metal Toxicity -- 9.Phytotherapies For Thyroidism: An Overview -- 10.Phytochemicals As Antidepressants -- 11.Phytochemistry And Medicinal Vaule Of Putranjiva Roxburghii Wall -- 12.Traditional Herbal Practices Of Eastern Ghats, Odisha, India For Treatment Of Bone Fracture -- 13.Screening Of Certain Medicinal Plants Of Manipur For Its Antifungal Activity Against Candida Species -- 14.Phytochemicals And Pharmaceutical: Overview -- 15.Millettia Pachycarpa Benth, A Herbal Medicinal Plant Of Southeast Asia -- 16.Phytochemicals And Their Role In Pharmaceuticals -- Section 2. Drug Discovery, Pharmaceutical Sciences And Future Medicine -- 17.Plant- Mediated Green Synthesis Of Nanoparticles -- 18.Biomedical Applications Of Green Synthesized Nanoparticles -- 19.Role Of Nanoparticles And Nanomaterials In Drug Delivery: An Overview -- 20.Micelleplexes: A Promising Nanocarriers For The Transport Of Genetic Material And Drugs -- 21.Phytomedicines And Their Prospects In Treatment Of Common Skin Diseases -- 22.Microbes As Natural Products For Drug Discovery -- 23.Natural Products From Actinobacteria For Drug Discovery -- 24.Anti – Leprosy Vaccine (Hansen’s Disease Vaccine) -- 25.Exploitation Of Fibrinolytic Enzymes In Combating Blood Clotting Disorders - Recent Advances And Strategies: A Comprehensive Review -- 26.Recent Development In Chronic Inflammation Research And Mangroves As Potential Source Of Anti-Inflammatory Agents -- Section 3. Clinical Trials And Ipr In Pharmaceuticals -- 27.Tissue Engineering And Regenerative Medicines: An Interdisciplinary Understanding -- 28.Ipr: An Overview -- 29.Intellectual Property Rights And Its Role In Natural Product Research -- 30.Nanotechnology In Preclinical Pharmacokinetics. |
| Record Nr. | UNINA-9910733708703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coronary Artery Disease: Therapeutics and Drug Discovery / / edited by Miao Wang
| Coronary Artery Disease: Therapeutics and Drug Discovery / / edited by Miao Wang |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (IX, 339 p. 7 illus., 4 illus. in color.) |
| Disciplina | 617.412 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Pharmacology
Cardiology Pharmacotherapy Cardiac surgery Pharmacology/Toxicology Cardiac Surgery Malalties coronàries Quimioteràpia Cirurgia cardíaca |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-2517-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease. |
| Record Nr. | UNINA-9910409701203321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis, management and emerging strategies for chemotherapy-induced neuropathy : a MASCC book / / Maryam Lustberg, Charles Loprinzi, editors
| Diagnosis, management and emerging strategies for chemotherapy-induced neuropathy : a MASCC book / / Maryam Lustberg, Charles Loprinzi, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (265 pages) : illustrations |
| Disciplina | 616.87 |
| Soggetto topico |
Nerves, Peripheral - Diseases
Drugs - Side effects Drug-Related Side Effects and Adverse Reactions Peripheral Nervous System Diseases Neurotoxicity Syndromes Antineoplastic Agents - adverse effects Malalties del sistema nerviós Quimioteràpia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-78663-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | MASCC book |
| Record Nr. | UNINA-9910502614803321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Journal of chemotherapy
| Journal of chemotherapy |
| Pubbl/distr/stampa | Firenze, : Edizioni riviste scientifiche, [1989]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Chemotherapy
Drug Therapy Quimioteràpia |
| Soggetto genere / forma |
Periodicals.
Periodical Revistes electròniques |
| ISSN | 1973-9478 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910154550103321 |
| Firenze, : Edizioni riviste scientifiche, [1989]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicinal plants for lung diseases : a pharmacological and immunological perspective / / Kamal Dua [and five others], editors
| Medicinal plants for lung diseases : a pharmacological and immunological perspective / / Kamal Dua [and five others], editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (625 pages) |
| Disciplina | 616.248 |
| Soggetto topico |
Emphysema, Pulmonary - Alternative treatment
Lungs - Diseases, Obstructive - Alternative treatmenT Malalties del pulmó Plantes medicinals Medicina alternativa Quimioteràpia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-336-850-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910494558003321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Messenger RNA Therapeutics / / edited by Stefan Jurga, Jan Barciszewski
| Messenger RNA Therapeutics / / edited by Stefan Jurga, Jan Barciszewski |
| Autore | Jurga Stefan |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (451 pages) |
| Disciplina | 615.58 |
| Collana | RNA Technologies |
| Soggetto topico |
Medical genetics
Medicinal chemistry Nanomedicine Cancer - Treatment Medical Genetics Medicinal Chemistry Nanomedicine and Nanotoxicology Cancer Therapy Quimioteràpia Vacunes RNA |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-08415-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The Democratization of RNA Therapeutics -- Supramolecular Strategies for mRNA Delivery -- In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of 21st Century: Exploitation of Peptides as Carriers for their Intracellular Delivery -- Effective Delivery of mRNA Therapeutics and Vaccines Using Lipid Nanoparticles -- Messenger RNA Therapeutics -- Formulation, Delivery and Application of mRNA Therapeutics In Respiratory Diseases -- Clinical Applications of mRNA Formulated In Lipid Nanoparticles -- Preparation of Messenger RNA Loaded Nanomedicine Applied on Tissue Engineering And Regenerative Medicine -- Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics: Immune Activation By Ionizable Cationic Lipids -- Adjuvants, the Elephant in the Room for RNA Vaccines -- Addressing Skin with Modified mRNA Constructs for Novel Therapies -- mRNA-Based Cancer Immunotherapies -- From Bench to Bedside: The Journey of an mRNA Drug Candidate Into a Medicine -- Synthetic mRNA Gene Therapies for Chronic HBV Infection -- Delivery Vehicles for Self-Amplifying RNA -- Delivery Technologies of mRNA Vaccines -- Nanosystems: The Key in Formulations of mRNA for Several Pathologies -- Messenger RNA Nanoformulation For Cancer Vaccine -- Preparation of Synthetic mRNAs for In Vivo Applications – Overview and Considerations -- Messenger RNA for Prophylaxis -- Nuclear Export of mRNA with Disease Pathogenesis and Therapeutic Potentials -- Messenger RNA Therapeutics: Start of a New Era in Medicine -- mRNA Delivery Technologies for Therapeutic Applications. |
| Record Nr. | UNINA-9910595061703321 |
Jurga Stefan
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Overcoming antimicrobial resistance of the skin / / Stephen K. Tyring [and three others] editors
| Overcoming antimicrobial resistance of the skin / / Stephen K. Tyring [and three others] editors |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XVI, 255 p. 85 illus., 78 illus. in color.) |
| Disciplina | 616.506 |
| Collana | Updates in Clinical Dermatology |
| Soggetto topico |
Skin - Diseases - Treatment
Skin - Diseases - Microbiology Malalties de la pell Microbiologia Quimioteràpia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-68321-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I: Emerging Bacterial Resistance to Antibiotics -- Ch 1: Mechanisms of Bacterial Resistance -- Ch 2: Emerging Bacterial Infections -- Ch 3: Re-Emerging Bacterial Infections of the Skin -- Section II: Emerging Resistance to Antivirals -- Ch 4: Mechanisms of Nonretroviral Resistance -- Ch 5: Mechanisms of Retroviral Resistance -- Ch 6: Emerging Viral Infections -- Ch 7: Re-Emerging Viral Infections - Implications of Lack of Vaccination -- Section III: Emerging Resistance to Antifungals -- Ch 8: Mechanisms of Antifungal Resistance -- Ch 9: Emerging and Re-Emerging Fungal Infections -- Section IV: Emerging Resistance to Drugs for Protozoan and Helminth Infections -- Ch 10: Mechanisms of Anti-Protozoan/Helminth Drug Resistance -- Ch 11: Emerging and Re-Emerging Protozoan/Helminth Infections -- Section V: Innovative Therapies on the Forefront -- Ch 12: Phage Therapy -- Ch 13: The Role of Biofilms and the Microbiome -- Ch 14: New Classes of Broad-Spectrum Antibiotics and New Mechanisms of Delivery -- Ch 15: Phytocompounds -- Ch 16: Summary: Overcoming Antimicrobial Resistance of the Skin. . |
| Record Nr. | UNINA-9910484403303321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric Pharmacotherapy / / edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker
| Pediatric Pharmacotherapy / / edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (VIII, 538 p. 1 illus.) |
| Disciplina | 615.1083 |
| Collana | Handbook of Experimental Pharmacology |
| Soggetto topico |
Pharmacology
Pediatrics Quimioteràpia Pediatria |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-50494-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Anti-epileptic drugs in pediatrics -- Current and new therapies for Duchenne Muscular Dystrophy -- Lysosomal diseases -- Mitochondriopathies -- Endocrinology thyroid, pituitary, growth stimulant, growth reduction -- Bone disease – bisphosphonates -- Diabetes type 1 and 3 (insulin; sulfonylurea; others) -- Diabetes type 2 (metformin etc.) -- Dermatology – part 1 urticaria, atopic dermatitis -- Dermatology part 2, ichtyosis, psoriasis -- Cardiovascular part 1- catcholamines, inotropic -- Cardiovascular part 2 – antiarhythmica, anti hypertensives -- Nephrology – dialysis -- How to use drugs in obese children and adolescents -- Haematology – CSFs, erythropoietin -- Antiretroviral/HIV -- Clinical pharmacology and pharmacometrics to better understand physiological changes during pregnancy and neonatal life -- Antihelminth treatment -- Inflammatory bowel disease -- Constipation; laxatives -- Psychiatric diseases in children and adolescents -- Oncology – cell reducing agents part 1, part 2, part 3 -- Immunosuppressants – organ transplantation -- Bone marrow/stem cell transplantation -- Narcotic sparing approaches and the shift towards paracetamol in neonatal intensive care -- Disorders of puberty: pharmacotherapeutic strategies for management. |
| Record Nr. | UNINA-9910416107603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pocket handbook of GI pharmacotherapeutics / / edited by Achilles Pappano, George Y. Wu
| Pocket handbook of GI pharmacotherapeutics / / edited by Achilles Pappano, George Y. Wu |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (276 pages) |
| Disciplina | 610 |
| Collana | Clinical Gastroenterology |
| Soggetto topico |
Medicine
Toxicology Gastroenterology Quimioteràpia Gastroenterologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-72592-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Relative Cost -- Contents -- Contributors -- 1: Gastroesophageal Disorders -- Meclizine -- Dimenhydrinate -- Ondansetron -- Scopolamine Patch -- Gastroesophageal Reflux Disorder (GERD) and Peptic Ulcer Disease (PUD) -- Proton Pump Inhibitors (PPI) -- Omeprazole -- Esomeprazole Magnesium (Oral) -- Esomeprazole Sodium (IV) -- Lansoprazole -- Pantoprazole Sodium Oral and IV -- Rabeprazole Sodium -- Dexlansoprazole -- Histamine H2 Antagonists -- Famotidine -- Other Agents -- Sucralfate -- Suggested Reading -- 2: Gastrointestinal Bleeding -- Pantoprazole -- Esomeprazole -- Octreotide Acetate -- Vasopressin -- Metoclopramide -- Erythromycin -- Epinephrine -- Hemostatic Nanopowder -- Suggested Reading -- 3: Specific Gastrointestinal Motility Disorders -- Nifedipine -- Botulinum Toxin (Onabotulinum Toxin A) -- Isosorbide Dinitrate -- Gastroparesis -- Erythromycin -- Metoclopramide -- Azithromycin -- Prucalopride -- Domperidone -- Dumping Syndrome and Accelerated Gastric Emptying -- Octreotide -- Dexlansoprazole -- Rapid Transit Dysmotility of the Small Bowel -- Loperamide -- Suggested Reading -- 4: General Gastrointestinal Motility Disorders -- Diarrhea -- Dicyclomine Hydrochloride -- Hyoscyamine Sulfate -- Diphenoxylate Hydrochloride/Atropine Sulfate -- Loperamide -- Cholestyramine -- Imipramine -- Amitriptyline -- Constipation -- Psyllium -- Methylcellulose -- Docusate -- Magnesium Citrate -- Mineral Oil -- Polyethylene Glycol -- Lactulose -- Senna -- Bisacodyl -- Castor Oil -- Lubiprostone -- Linaclotide -- Plecanatide -- Prucalopride -- Irritable Bowel Syndrome-Diarrhea Predominant (IBS-D) -- Rifaximin -- Alosetron -- Eluxadoline -- Irritable Bowel Syndrome-Constipation Predominant (IBS-C) -- Tegaserod -- Tenapanor -- Suggested Reading -- 5: Inflammatory Bowel Disease -- Sulfasalazine -- Mesalamine -- Olsalazine -- Balsalazide.
Glucocorticoids: Prednisone, Methylprednisolone and Hydrocortisone -- Budesonide -- Hydrocortisone Retention Enema -- 6-Mercaptopurine (6-MP) -- Azathioprine -- Methotrexate (MTX) -- Cyclosporine -- Infliximab -- Adalimumab -- Certolizumab Pegol -- Golimumab -- Natalizumab -- Vedolizumab -- Ustekinumab -- Tofacitinib -- Suggested Monitoring for IBD Drugs -- Suggested Reading -- 6: General Gastrointestinal Infections -- Treatment of Acute Diverticulitis -- Cefotaxime -- Ceftriaxone -- Cefepime -- Metronidazole -- Levofloxacin -- Ciprofloxacin -- Sulfamethoxazole and Trimethoprim -- Piperacillin-Tazobactam -- Ertapenem -- Infective Endocarditis Prophylaxis for GI Procedures -- Suggested Reading -- 7: Specific Gastrointestinal Microbial Infections -- Clostridioides (formerly Clostridium) difficile Pseudomembranous Colitis -- Vancomycin -- Fidaxomicin -- Metronidazole -- Helicobacter pylori -- Amoxicillin -- Bismuth Subsalicylate -- Clarithromycin -- Levofloxacin -- Tinidazole -- E. coli (EP and EI) Gastroenteritis -- Shigella Colitis -- Salmonella Gastroenteritis -- Campylobacter Gastroenteritis -- Vibrio cholerae -- Yersinia Gastroenteritis -- Listeria monocytogenes -- Trimethoprim-Sulfamethoxazole -- Ciprofloxacin -- Whipple Disease -- Azithromycin -- Erythromycin -- Doxycycline -- Tetracycline -- Fungal Infections -- Fluconazole -- Voriconazole -- Caspofungin -- Clotrimazole -- Cryptosporidium hominis -- Cyclospora cayetanensis -- Nitazoxanide -- Viral Infections -- Ganciclovir -- Valganciclovir -- Foscarnet -- Protozoan Infections -- Amebiasis -- Giardiasis -- Parasitic Infestations -- Ascariasis (A. lumbricoides) -- Cutaneous Larva Migrans -- Cysticercosis (Taenia solium) -- Dracunculiasis (Guinea Worm Disease) -- Echinococcosis (Hydatid Cyst) -- Enterobiasis (Pinworm) -- Hook Worm (Ancylostomiasis). Lymphatic Filariasis (W. bancrofti, B. malayi, B. timori) -- Loaisis (M. streptocerca, O. volvulus, D. medinensis) -- Tropical Pulmonary Eosinophilia -- Trypanosoma cruzi (Chagas Disease) -- Onchocerciasis (River Blindness) -- Fluke Infections -- Schistosomiasis -- Strongyloidiasis -- Tapeworm Intestinal Infections (Taenia saginata) -- Trichinellosis (Roundworm) -- Trichuriasis (Whipworm) -- Albendazole -- Mebendazole -- Ivermectin -- Praziquantel -- Thiabendazole: No Longer Available in the USA -- Pyrantel Pamoate -- Tinidazole -- Paromomycin -- Iodoquinol -- Diethylcarbamazine -- Benznidazole -- Triclabendazole -- Suggested Reading -- 8: Hepatitis -- Chronic Hepatitis B -- Entecavir -- Tenofovir Dipovoxil Fumarate (TDF) -- Tenofovir Alafenamide (TAF) -- Pegylated Interferon α-2a -- Dosage Adjustments for PEG-Interferon α-2a (Pegasys) -- Pegylated Interferon α-2b -- Dosage adjustments for PEG-interferon α-2b: -- Lamivudine -- Adefovir Dipivoxil -- Chronic Hepatitis C -- Sofosbuvir -- Ledipasvir/Sofosbuvir -- Glecaprevir/Pibrentasvir -- Elbasvir/Grazoprevir -- Sofosbuvir/Velpatasvir/Voxilaprevir -- Daclatasvir -- Ribavirin -- Ribavirin Dosage Adjustments -- Pegylated Interferon α-2a -- Autoimmune Hepatitis -- Azathioprine -- Prednisone -- Budesonide -- Mycophenylate Mofetil (MMF) -- Alcoholic Hepatitis -- Prednisolone -- Suggested Reading -- 9: Portal Hypertension -- Nadolol -- Propranolol -- Carvedilol -- Suggested Reading -- 10: Cholestasis -- Primary Biliary Cholangitis (PBC) -- Ursodiol, Ursodeoxycholic Acid (UDCA) -- Obeticholic Acid (OCA) -- Primary Sclerosing Cholangitis (PSC) -- UDCA -- Suggested Reading -- 11: Hepatic Encephalopathy -- Lactulose -- Neomycin -- Rifaximin -- Suggested Reading -- 12: Ascites -- Ascites Management -- Furosemide -- Spironolactone -- Spontaneous Bacterial Peritonitis (SBP) -- Cefotaxime -- Ofloxacin -- Ceftriaxone. Norfloxacin -- Trimethoprim-Sulfamethoxazole -- Albumin -- Suggested Reading -- 13: Overload Disorders -- Hereditary Hemochromatosis -- Deferoxamine -- Deferasirox -- Wilson's Disease -- Penicillamine -- Trientine -- Tetrathiomolybdate -- Zinc Sulfate -- Gaucher's Disease -- Imiglucerase (Glucocerebrosidase) -- Velaglucerase Alfa (Glucocerebrosidase) -- Taliglucerase Alfa -- Miglustat -- Eliglustat -- Suggested Reading -- 14: Pruritus -- Diphenhydramine -- Hydroxyzine -- Cholestyramine -- Rifampin -- Ursodeoxycholic Acid -- Naltrexone -- Sertraline -- Suggested Reading -- 15: Post-Liver Transplant -- Immunosuppressant Drugs -- Glucocorticoids -- Tacrolimus -- Cyclosporine -- Azathioprine -- Mycophenolate Mofetil -- Sirolimus -- Everolimus -- Infection Prophylaxis Agents -- Antifungal Prophylaxis -- PCP Prophylaxis -- Antiviral Prophylaxis -- Suggested Reading -- 16: Acute and Chronic Pancreatitis Pain Syndromes -- Tramadol -- Renal Insufficiency -- Hepatic Impairment -- Hydromorphone -- Gabapentin -- Amitriptyline -- Duloxetine -- Octreotide -- Celiac/Splanchnic Nerve Block -- Suggested Reading -- 17: Pancreatic Insufficiency -- Pancrelipase -- Suggested Reading -- 18: Gut Malabsorption and Enzyme Deficiencies -- Lactase Deficiency -- Lactase -- Vitamin B12 Deficiency/Pernicious Anemia -- Vitamin B12 (Cyanocobalamin) -- Vitamin B12 Deficiency -- Pernicious Anemia -- Small Intestinal Bacterial Overgrowth (SIBO) -- Non-absorbable Antibiotics -- Systemic Antibiotics -- Neomycin -- Short Bowel Syndrome (SBS) -- Antisecretory Agents -- Antimotility Agents -- Codeine -- Tincture of Opium -- Bile Acid Binders -- Intestinotrophic Factors -- Suggested Reading -- Appendix A: Pregnancy and Lactation Labeling Rule -- Appendix B: Abbreviations -- Index. |
| Record Nr. | UNINA-9910492146903321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rare Disease Drug Development : Clinical, Scientific, Patient, and Caregiver Perspectives / / edited by Raymond A. Huml
| Rare Disease Drug Development : Clinical, Scientific, Patient, and Caregiver Perspectives / / edited by Raymond A. Huml |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (417 pages) |
| Disciplina | 615.19 |
| Soggetto topico |
Medicine
Clinical medicine - Research Pharmacology Immunology Therapeutics Pharmacovigilance Clinical Medicine Clinical Research Drug Safety and Pharmacovigilance Malalties rares Desenvolupament de medicaments Quimioteràpia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-78605-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction to Rare Diseases and Market Overview -- The Patient Perspective -- Select Patient Narratives -- The Caregiver Perspective -- The Critical, Multidimensional Role of Patient Advocacy Groups in Rare Disease -- A Mental Health Perspective -- Investment Decisions Related to Rare Disease Drug Development -- Optimizing Rare Disease Registries and Natural History Studies -- Novel Approaches to Clinical Trials in Rare Diseases -- Patient Benefits from Innovative Designs in Rare Diseases -- Central Nervous System Rare Disease Drug Development -- Oncologic Rare Disease Drug Development -- Hematologic Rare Disease Drug Development -- Lessons From Rare Disease and Gene Therapy Clinical Studies in Ophthalmology -- Rare Diseases in the Pediatric Population -- Cell and Gene Therapy in Rare Diseases -- The Feasibility Assessment -- The Evolving Regulatory Space and the Advent of Patient-Focused Drug Development -- Operational Aspects of Rare Disease Drug Development -- Accelerating Rare Disease Drug Development -- Select Rare Disease Drug Approvals: Lessons Learned -- A Rapid Market Access Strategy for Orphan Medicinal Products (OMPs) with Highlights Regarding the Pricing and Reimbursement Process and Barriers to Patient Use -- Integrated Life Cycle Management for Rare and Orphan Products -- The Case for Real-World Data and Real-World Evidence Generation in Rare and Orphan Medicinal Drug Development -- Closing Remarks -- . |
| Record Nr. | UNINA-9910508447303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
